In patients presenting with ST-segment elevation myocardial infarction (STEMI) and multi-vessel disease (MVD), the optimal therapy for non-culprit lesions is still a matter of debate. 
THE DILEMMA OF NON-CULPRIT LESIONS AND PRIMARY PERCUTANEOUS CORONARY INTERVENTION
Early and successful recanalization of the infarct-related artery is the principal treatment goal in patients presenting with acute STsegment elevation myocardial infarction (STEMI) [1, 2] . In about half of the STEMI patients, coronary angiography reveals multivessel disease (MVD) with at least one angiographically significant lesion in a noninfarct-related artery [1] [2] [3] [4] . STEMI patients with MVD have been identified as a high-risk cohort with lower reperfusion success and poorer longterm outcome since the early days of primary percutaneous coronary intervention (PCI) [5] , Intuitively, the treatment of non-culprit lesions during primary PCI is beneficial, as the reperfusion success should be more profound and subsequent cardiac events might be avoided. However, large registries have reported conflicting outcomes and generally the opposite [6] [7] [8] [9] [10] [11] [12] . In some of these registries, the culprit-only strategy has even been associated with a lower mortality than complete multi-vessel revascularization. This underscored the risk of an ad-hoc multi-vessel stenting, probably explained by a prothrombotic and inflammatory milieu, additional contrast load and damaged left ventricular function in the acute phase. This promoted the assumption of an increased hazard from multi-vessel PCI in acute patients.
Consequently, practice guidelines recommended to confine primary PCI to the infarct-related artery only, and to potentially treat other lesions later on, depending on the evidence of residual myocardial ischemia [1, 2] .
The culprit-only strategy may also be preferred as coronary stenoses remote from the infarct related artery could be angiographically overestimated in the acute setting, and lesions may regress when coronary spasm resolves.
These observations may reflect a heightened vascular tone in infarct-and non-infarct-related arteries, and indicate that non-culprit lesions may not be a valid target in primary PCI, at least in hemodynamically stable patients [13] Common sense has changed to some extent with the recent publication of randomized [26] . Such lesions could be easily The main disadvantage of FFR measurement at the time of primary PCI is the need for additional instruments, radiation, and contrast, and-even if performed by experienced operators-it will prolong the procedure. The need for achieving maximal hyperemia usually d Fractional flow reserve of the RCA was 0.83, and the decision about the non-culprit vessel based on functional assessment was possible during the primary intervention. However, the rationale of this strategy is being tested in a current trial with adenosine could be problematic in patients with asthma or a preexisting high degree atrioventricular-block (HAVB). However, the incidence of HAVB in patients with acute coronary syndrome is low. Singh et al. reported an incidence of HAVB of 2.9 % at any point during the index hospitalization for an acute coronary syndrome [28] . Gang et al. reported an overall incidence of 3.2 % in patients with acute MI, but culprit lesions in the right coronary artery were associated with a significantly higher rate (7 %) [29] . Moreover, the presence of cardiogenic shock, severe hypotension or bradycardia may limit the use of adenosine-derived FFR. The recently introduced instant wave-free ratio and the basal stenosis resistance are modalities for functional assessment of coronary artery stenosis that are adenosine-independent [30, 31] , and these methods may have a future in patients with contraindications for adenosine.
Nevertheless, the very short half-life of adenosine makes measurements possible without complications in the majority of these cases. In fact, many trials report no or very low rates of FFR-related complications, even in acute coronary syndromes [32] [33] [34] .
Although current data have confirmed the reliability and safety of FFR measurements in 
